Product
clevidipine
Aliases
clevidipine butyrate, Cleviprex
Name
Cleviprex
INN Name
clevidipine
FDA Approved
Yes
2 clinical trials
1 organization
5 indications
1 document
Indication
Subarachnoid HemorrhageIndication
Cerebral AneurysmIndication
vasospasmIndication
IntracranialClinical trial
Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing SurgeryStatus: Withdrawn, Estimated PCD: 2024-02-20
Clinical trial
Clevidipine for Vasospasm After Subarachnoid HemorrhageStatus: Withdrawn, Estimated PCD: 2018-03-01
Document
DailyMed Label: CleviprexOrganization
Fresenius Kabi Austria GmbH